Hjem › Multipelt myelom › New Hampshire
Kliniske studier for Multipelt myelom i New Hampshire
4 studier for Multipelt myelom søker deltakere på steder i New Hampshire.
Offisiell studietekst (engelsk)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Dartmouth Hitchcock Medical Center, Lebanon
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05552222TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NH Oncology - Hematology, PA, Concord
- Solinsky Center for Cancer Care, Manchester
- New England Cancer Specialist, Portsmouth
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT02693535A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
- Dartmouth-Hitchcock Medical Center, Lebanon
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 12. aug. 2026 · NCT07280013Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Exeter Hospital, Exeter
RekruttererFase 3
Alle aldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT05561387Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.